Acme Resources Overview

  • Founded
  • 2008
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 8
  • Investments
  • 1

Acme Resources General Information


Rapid Dose Therapeutics Corp, formerly Acme Resources Corp is a bio-technology company which, through its subsidiaries, provides proprietary enhanced drug delivery technologies designed to improve patient outcomes. The company through its subsidiary, owns a proprietary oral fast-dissolving drug delivery system, QuickStrip, which is capable of rapidly releasing into the blood stream a variety of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Primary Office
  • 20 Adelaide Street East
  • Suite 200
  • Toronto, Ontario M5C 2T6
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Acme Resources Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acme Resources‘s full profile, request access.

Request a free trial

Acme Resources Executive Team (1)

Name Title Board Seat Contact Info
Paul Ankcorn Chief Executive Officer
To view Acme Resources’s complete executive team members history, request access »

Acme Resources Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000 00 07-Dec-2018 0000000 00 Drug Discovery
To view Acme Resources’s complete acquisitions history, request access »